Atlas Trials

A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status

Clinical trial NCT03665402 · COMPLETED

Trial details

NCT number
NCT03665402
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
TuberculosisDrug-Induced Liver InjuryAdverse Drug Event
Start date
2018-05-13
Primary completion
2018-12-31
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.